Company / Operating Margin
Bio-Rad Laboratories Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
1.8%
FY2025
5-year range
1.8% / 17.2%
FY2021-FY2025
Trend
-82.5%
vs FY2024
Sector context
#91 of 148
Health Care
What the data says
At 1.8%, Bio-Rad Laboratories's operating margin ranks #91 of 148 in the Health Care sector. Operating Margin has declined for 3 consecutive years, from 17.2% in FY2022 to 1.8% in FY2025.
Based on SEC 10-K filings.
1.8% in FY2025 with a 5-year CAGR of +6.3%.
Declined from 12.7% to 1.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -15.4pp
- 5-Year Change
- +6.3pp
- 10-Year Change
- -
Sector benchmark
#91 of 148 in Health CareTop 61% of 148This company 1.8% Sector average -284.8%
▼
+100.6% above sector average
Key checks
Key Insights
- Bio-Rad Laboratories's operating margin has declined for 3 consecutive years.
- In FY2025, operating margin decreased 82.5% year-over-year.
- Currently 286.6pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.8% | -82.5% |
| FY2024 | 10.5% | -17.2% |
| FY2023 | 12.7% | -26.5% |
| FY2022 | 17.2% | +0.6% |
| FY2021 | 17.1% | +479.6% |
| FY2020 | -4.5% | -145.4% |
| FY2019 | 9.9% | +269.1% |
| FY2018 | 2.7% | -67.4% |
| FY2017 | 8.3% | +19.7% |
| FY2016 | 6.9% | -16.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026